These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 11129276)
1. Disappearance of "pseudocholangiocarcinoma sign" in a patient with portal hypertension due to complete thrombosis of left portal vein and main portal vein web after web dilatation and transjugular intrahepatic portosystemic shunt. Bayraktar Y; Oztürk MA; Egesel T; Cekirge S; Balkanci F J Clin Gastroenterol; 2000 Dec; 31(4):328-32. PubMed ID: 11129276 [TBL] [Abstract][Full Text] [Related]
2. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein. Wang L; He F; Yue Z; Zhao H; Fan Z; Zhao M; Qiu B; Yao J; Lin Q; Dong X; Liu F Sci Rep; 2017 Sep; 7(1):10868. PubMed ID: 28883536 [TBL] [Abstract][Full Text] [Related]
3. Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis. Uflacker R Tech Vasc Interv Radiol; 2003 Mar; 6(1):59-69. PubMed ID: 12772131 [TBL] [Abstract][Full Text] [Related]
4. [Portal vein thrombosis after occlusion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS). Shunt dilatation with subsequent local and systemic thrombolysis]. Gabler R; Barnert J; Bohndorf K; Eberl T; Wienbeck M Dtsch Med Wochenschr; 1997 Feb; 122(7):188-92. PubMed ID: 9072489 [TBL] [Abstract][Full Text] [Related]
5. Disappearance of the pseudo-cholangiocarcinoma sign after TIPSS. Görgül A; Kayhan B; Dogan I; Unal S Am J Gastroenterol; 1996 Jan; 91(1):150-4. PubMed ID: 8561119 [TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179 [TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertensive biliopathy with cavernous transformation of the portal vein: a case report. Zhao M; Wang X; Liu B; Luo X BMC Gastroenterol; 2022 Mar; 22(1):96. PubMed ID: 35240998 [TBL] [Abstract][Full Text] [Related]
8. Transjugular portosystemic shunt in chronic portal vein occlusion: importance of segmental portal hypertension in cavernous transformation of the portal vein. Walser EM; Soloway R; Raza SA; Gill A J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):373-8. PubMed ID: 16517786 [TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. Jiang ZB; Shan H; Shen XY; Huang MS; Li ZR; Zhu KS; Guan SH World J Gastroenterol; 2004 Jul; 10(13):1881-4. PubMed ID: 15222028 [TBL] [Abstract][Full Text] [Related]
10. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy. Luo SH; Chu JG; Huang H; Zhao GR; Yao KC World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997 [TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation. Wils A; van der Linden E; van Hoek B; Pattynama PM J Clin Gastroenterol; 2009; 43(10):982-4. PubMed ID: 19417681 [TBL] [Abstract][Full Text] [Related]
12. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Rodrigues SG; Sixt S; Abraldes JG; De Gottardi A; Klinger C; Bosch J; Baumgartner I; Berzigotti A Aliment Pharmacol Ther; 2019 Jan; 49(1):20-30. PubMed ID: 30450634 [TBL] [Abstract][Full Text] [Related]
13. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft. Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy Jiang TT; Luo XP; Sun JM; Gao J World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701 [TBL] [Abstract][Full Text] [Related]
16. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651 [TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous Mesocaval Shunt Creation in a Patient with Chronic Portal and Superior Mesenteric Vein Thrombosis. Bercu ZL; Sheth SB; Noor A; Lookstein RA; Fischman AM; Nowakowski FS; Kim E; Patel RS Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1316-9. PubMed ID: 25189666 [TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541 [TBL] [Abstract][Full Text] [Related]
20. Stepwise placement of a transjugular intrahepatic portosystemic shunt endograft. Clark TW Tech Vasc Interv Radiol; 2008 Dec; 11(4):208-11. PubMed ID: 19527846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]